Europlasma SA (PA:ALEUP) — Stock Price

€0.00 EUR
▲ 0.00% today

Europlasma SA (PA:ALEUP) is currently trading at €0.00 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.00 and €1.75. This page tracks Europlasma SA's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Europlasma SA worth.

Europlasma SA (ALEUP) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Europlasma SA's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Europlasma SA Income Statement — Revenue, Profit & Earnings by Year

Europlasma SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €42.45 Million €15.41 Million €14.52 Million €9.80 Million €3.79 Million
Cost of Revenue €63.04 Million €32.82 Million €28.27 Million €19.39 Million €12.62 Million
Gross Profit €-20.59 Million €-17.41 Million €-13.75 Million €-9.59 Million €-8.82 Million
Research & Development €60.00K
SG&A €22.47 Million €11.52 Million €12.24 Million €3.62 Million €1.89 Million
Total Operating Expenses €5.97 Million €2.56 Million €2.58 Million €2.04 Million €3.57 Million
Operating Income €-26.57 Million €-19.97 Million €-16.33 Million €-11.62 Million €-12.39 Million
EBITDA €-3.36 Million €-3.84 Million €-5.30 Million €-3.14 Million €5.94 Million
EBIT €-15.52 Million €-11.52 Million €-10.34 Million €-5.63 Million €5.06 Million
Interest Expense €3.15 Million €3.58 Million €5.66 Million €6.89 Million €15.70 Million
Income Before Tax €-18.66 Million €-15.10 Million €-15.99 Million €-12.97 Million €-10.64 Million
Income Tax Expense €-2.75 Million €-355.00K €-241.00K €-299.00K €-759.00K
Net Income €-15.29 Million €-14.74 Million €-15.92 Million €-12.67 Million €-9.88 Million

Europlasma SA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Europlasma SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €62.90 Million €45.26 Million €54.67 Million €40.44 Million €26.30 Million
Total Current Assets €38.66 Million €14.61 Million €17.00 Million €13.36 Million €12.10 Million
Cash & Equivalents
Short-term Investments €4.00K €4.00K €10.00K €10.00K €10.00K
Net Receivables €16.68 Million €4.89 Million €7.38 Million €5.68 Million €6.64 Million
Inventory €17.84 Million €7.87 Million €6.63 Million €3.01 Million €816.00K
Property, Plant & Equipment €19.53 Million €24.18 Million €29.06 Million €19.15 Million €8.18 Million
Goodwill €82.00K €-1.00K €0.00 €8.00K €8.00K
Total Liabilities €74.05 Million €50.02 Million €48.86 Million €35.97 Million €42.75 Million
Total Current Liabilities €50.30 Million €31.08 Million €27.44 Million €21.65 Million €32.47 Million
Long-term Debt €10.18 Million €6.22 Million €3.04 Million €2.29 Million €442.00K
Net Debt €11.51 Million €10.32 Million €5.95 Million €1.70 Million €3.43 Million
Total Stockholder Equity €-10.41 Million €-4.01 Million €6.56 Million €5.35 Million €-15.58 Million
Retained Earnings €-229.92 Million €-214.63 Million €-199.89 Million €-183.97 Million €-171.29 Million

Europlasma SA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Europlasma SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €-11.47 Million €-10.43 Million €-10.48 Million €-18.33 Million €-12.33 Million
Capital Expenditures €1.52 Million €1.73 Million €2.90 Million €5.42 Million €4.77 Million
Free Cash Flow €-12.98 Million €-12.17 Million €-13.38 Million €-23.75 Million €-17.11 Million
Investing Cash Flow €-2.09 Million €-953.00K €-4.16 Million €-5.70 Million €-5.76 Million
Financing Cash Flow €14.14 Million €10.14 Million €14.56 Million €22.25 Million €19.53 Million
Dividends Paid
Stock-Based Compensation €0.00 €388.00K €3.00K
Depreciation €12.16 Million €7.68 Million €5.03 Million €2.49 Million €881.00K
Change in Cash €587.00K €-1.25 Million €-66.00K €-1.68 Million €1.44 Million

Europlasma SA Earnings History — EPS Actual vs. Analyst Estimates

Track Europlasma SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 27, 2025 -97.49 0.00
Jun 11, 2025 -85.86
Oct 30, 2024 5.00 0.00
May 29, 2024 0.00 0.00
Feb 28, 2024 0.00 0.00
Oct 27, 2023 0.00 0.00
Aug 30, 2023 0.00 0.00
Apr 26, 2023 0.00 0.00